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The 1990 Clean Air Act mandated oxygenation ofgasoline in regions where carbon monoxide
standards were not met. To achieve this standard, methyl tertiary butyl ether (MTBE) was
increased to 15% byvolumeduringwinter months inmanylocations. Subsequentto theincrease
ofMTBE in gasoline, commuters reported increases in symptoms such as headache, nausea, and
eye, nose, andthroatirritation. Thepresent studycompared 12 individuals selectedbasedon self-
report ofsymptoms (self-reported sensitives; SRSs) associatedwith MTBE to 19 controls without
self-reported sensitivities. In a double-blind, repeated measures, controlled exposure, subjects
wereexposed for 15 minto dean air, gasoline, gasolinewith 11% MTBE, andgasolinewith 15%
MTBE. Symptoms, odor ratings, neurobehavioral performance on a task ofdriving simulation,
and psychophysiologic responses (heart and respiration rate, end-tidal CO2, fingerpulse volume,
electromyograph, finger temperature) were measured before, during, and immediatelyafter expo-
sure. Relative to controls, SRSs reported significantly more total symptoms when exposed to
gasoline with 15% MTBE than when exposed to gasoline with 11% MTBE or to dean air.
However, these differences in symptoms were not accompanied bysignificant differences in neu-
robehavioral performance orpsychophysiologic responses. No significantdiferences insymptoms
orneurobehavioral orpsychophysiologic responses wereobservedwhen exposure togasolinewith
11% MTBEwas compared to dean air or to gasoline. Thus, thepresent study, although showing
increased total symptoms among SRSs when exposed to gasolinewith 15% MTBE, did not sup-
port a dose-response relationship for MTBE exposure nor the symptom specificity associated
with MTBE in epidemiologic studies. Key workls controlled exposure, methyl tertiarybutyl ether,
neurologic, psychophysiology, self-reported sensitives, symptoms. Environ Health Perspect
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Until the fall of 1992, methyl tertiary butyl
ether (MTBE) was used as an octane
enhancer in premium gasolines. To bring
several regions ofthe United States into com-
pliance with the National Ambient Air
Quality Standards for carbon monoxide, the
1990 Clean Air Act (1) mandated 2.7% by
weight oxygen concentration in cold season
fiuels and 2.0% byweight oxygen duringpho-
tochemical smog season. Although both
MTBE and ethanol can be used to oxygenate
fuel, MTBE was thechemical mostfrequently
chosen foroxygenation.
This increase to 15% MTBE in gasoline
was followed by acute health complaints in
several regions of New Jersey and Alaska
(2,3). Subsequent cross-sectional community
studies ofhealthy workers suggested that the
highest blood levels ofMTBE were associat-
ed with more symptoms (4-6). Controlled
exposures to pure MTBE, however, did not
show increased symptom reports or neurobe-
havioral performance deficits in healthy
young adults (7-9). To date, no controlled
exposure to MTBE has directly evaluated the
symptoms and health effects that were report-
ed anecdotally by a subset of individuals
(7,10). Therefore, the purpose ofthe present
controlled exposure study was to compare the
symptoms, psychophysiologic reactivity, and
neurobehavioral performance ofpersons who
reported sensitivity to MTBE and controls in
response to four controlled exposure condi-
tions: clean air, gasoline, gasoline with 11%
MTBE, andgasolinewith 15% MTBE.
Three controlled exposure studies have
investigated the effect of pure MTBE on
symptoms and objective measures of irrita-
tion and performance in healthy subjects.
Measures ofeye and nasal inflammation were
chosen as physiologic measures of reported
irritant symptoms; neurobehavioral measures
were performance-based indicators of symp-
toms, such as disorientation, presumed to
interfere with tasks that rely on speed of
response (e.g., driving).
Using a double-blind cross-over design,
Prah et al. (8) exposed healthy subjects to
1.4 ppm MTBE versus clean air for 1 hr.
Cain et al. (9) exposed healthy subjects for 1
hr to each of three conditions: 1.7 ppm
MTBE, 7.1 ppm mixture of 17 volatile
organic compounds, and clean air. Neither
study found an increase in symptoms, a
reduction in neurobehavioral performance,
or changes on measures ofeye irritation (tear
film breakup). The number of polymor-
phonuclear neutrophil leukocytes in nasal
lavage fluid samples was increased only
18-24 hr after exposure to volatile organic
compounds (9). In these studies, blood levels
ofMTBE were higher than the upper quar-
tile levels assessed in the cross-sectional stud-
ies ofworkers. More recently, Nihlen et al.
(7) exposed 10 healthy males to 5, 25, and
50 ppm MTBE and found that subjects
reported significantly higher ratings of sol-
vent smell with higher exposure to MTBE.
Ratings ofodor declined over time, suggest-
ing habituation to the odor. No increase in
symptoms or changes in objective measures
ofeye irritation was observed (e.g., tear film
breakup time, redness). Nasal airway resis-
tance increased significantly after exposure,
but the effect was not correlated with expo-
sure. Thus, in healthy subjects, MTBE expo-
sures under controlled conditions did not
replicate the symptoms reported either anec-
dotally or in cross-sectional community
studies. These controlled exposures to
MTBE, however, were not those of typical
exposures such as refueling or driving, where
MTBE is encountered only as an additive to
gasoline. Moreover, controlled exposure
studies to date have not included self-report-
ed sensitive individuals.
As is observed with other noxious odor-
ants, symptomatic complaints in response to
MTBEingasolinecouldbesecondary to emo-
tional responses evoked by unpleasant odor
(11,14. The association between odor, emo-
tion, and physiologic arousal has been used to
investigate psychologic and physiologic
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responses to various pleasant and unpleasant
odors (13,14). For example, subjects with
greater fear of undergoing dental work
responded with increased autonomic arousal
(i.e., electrodermal changes) to eugenol, an
odorant associated with dental procedures
(15). The hypothesis of a relationship
between the odor of MTBE and a sympto-
matic response to MTBE is further substanti-
ated by the overlap between reported key
symptoms (i.e., eye irritation, burning sensa-
tion in nose or throat, headache, nausea or
vomiting, cough, sensations of"spaciness" or
disorientation, dizziness) and those associated
with anxiety and/or hyperventilation (e.g.,
spaciness, dizziness). Therefore, in addition
to measuring symptoms and simulated dri-
ving performance, psychophysiologic changes
associated with symptoms ofanxiety such as
increased heart and respiration rate, reduced
blood pulse volume in the periphery, and
increased end-tidal CO2 were measured in
response to exposure.
The present study evaluated symptoms,
psychophysiologic responses, and neurobe-
havioral performance ofself-reported sensitive
individuals (SRSs) and controls. In addition
to clean air and gasoline, subjects were
exposed to 15% MTBE and 11% MTBE in
gasoline at concentrations similar to those
documented during refueling (16). This
controlled exposure study was intentionally
designed to test directly the anecdotal
reports ofself-reported sensitivity to MTBE
in gasoline. Moreover, by including psy-
chophysiologic measures, we sought to
distinguish symptoms secondary to an emo-
tional response (e.g., anxiety) evoked by the
odor of the exposure from those resulting
directly from exposure.
Methods
Subject Recruitment
SRS subjects from throughout New Jersey
were recruited through radio and newspaper
advertisements and letters sent to members of
the mailing lists for the activist group
Oxybusters (Plainsboro, NJ), the National
Reformulated Gas Hotline ofthe Oxygenated
Fuels Association (Arlington, VA), and the
New Jersey Department of Environmental
Protection (Trenton, NJ). Individuals inquir-
ing about the study from advertisements
(n 700) and members of the mailing lists
(n = 800) were sent an introductory letter
describing the study, a general health
screening questionnaire, and a survey of 34
symptoms. The symptom survey asked the
individual to rate the level ofdiscomfort asso-
ciated with each symptom on a scale from 0
(do not have the symptom) to 3 (symptom is
severe) and then indicatewhether the discom-
fort occurred at a gas station or around traffic
exhaust and how long the symptom lasted.
For the purposes of this study, individuals
who scored 2 6 out of 21 points (total) on
MTBE-related symptoms reported to occur
around gasoline (headache, cough, nausea,
daytime sleepiness, burning sensation in nose
ormouth, losing balance ordizziness, difficul-
ty concentrating) (4) were classified as SRSs.
Controls were recruited by newspaper adver-
tisements and were sent the same screening
questionnaires as for SRS recruitment. A total
of287 (19%) screening forms were returned.
Twenty-five of the surveys could not be
scored due to incomplete information, leaving
262 to score andcategorize.
Ofthe questionnaires scored, 184 (70%)
were classified as controls and 78 (30%) as
SRSs. Afterclassification, individuals with any
of the following medical conditions were
excluded from participation: neurologic dis-
ease or history of brain injury, significant
exposure to neurotoxicants, stroke or cardio-
vascular disease, serious pulmonary disease
(e.g., asthma), liver or kidney disease, serious
gastrointestinal disorders, nasal polyps, nasal
surgery, sinus disease, chronic fatigue syn-
drome, multiple chemical sensitivities, or
major psychiatric disorders including psy-
choses, bipolar disorder, alcoholism, or drug
abuse. Smokers and pregnant or lactating
women were also excluded, as were individu-
als taking beta and alpha blockers, anxiolytics,
antidepressants, andsteroids.
The subjects who did not report any of
the above conditions underwent a complete
medical history and physical examination
with a standard laboratory blood chemistry
panel and electrocardiogram (EKG). Based
on the results of either the screening survey
or the physical examination, 53 controls and
28 SRSs were excluded from the study due
to medical conditions (e.g., diabetes, hyper-
tension, smoking) or medication use. Fifty-
three controls and 38 SRSs decided not to
participate for logistic reasons (e.g., moved,
time constraints), and 59 controls were not
invited to participate because they did not
demographically match the recruited SRSs.
Ofthe remaining 31 subjects, 19 were con-
trols and 12 were SRSs. The number of
SRSs was less than initially planned; howev-
er, no additional SRSs were either medically
fit or willing to participate. Subjects were
paid an incentive of $500 upon completion
of all exposure sessions. If all sessions were
not completed, a prorated amount was paid
to the subject. Thus, the SRS subjects were
those willing to participate, but also those
who did not have any major or chronic
physical orpsychological disorder.
Subjects
Twelve SRSs (6 males, 6 females), mean age
42.3 years (SD = 11.9, range = 23-65) and
19 controls (6 males, 13 females), mean age
39.1 (SD = 9.9, range = 24-65) (p = 0.38)
completed the protocol. SRSs had a mean of
17.1 (SD = 4.6, range = 12-18) years ofedu-
cation and the controls a mean of 14.9 years
(SD = 2.8, range = 12-23; p = 0.19). In the
SRS group there were 7 whites and 5 in vari-
ous ethnic groups, while the controls had 16
whites and 3 ofotherethnic origin (p = 0.17).
No significant differences in age, education,
sex (p = 0.31), or ethnicity distribution were
observed between SRSs and controls. SRSs
scored significantly higher than controls on
MTBE-related (SRS: mean = 9.83, SD =
2.33; control: mean = 0.58, SD = 1.07; t =
-12.93, p < 0.0001) and non-MTBE-relat-
ed symptoms (SRS: mean = 14.08; SD =
10.54; control: mean = 0.37; SD = 1.01; t=
-4.50, p < 0.001). Thus, on the screening
questionnaire, SRSs reported more symp-
toms than controls.
Measures
Bloodlevels ofMTBEandtertiarybutylalo-
hot Pre- and postexposure bloodwas sampled
from SRSs and controls for all experimental
conditions. Samples were analyzed by both
the Environmental and Occupational Health
Sciences Institute and the Centers for Disease
Control and Prevention (Atlanta, GA) for the
presence ofMTBE and its metabolite, tertiary
butyl alcohol (TBA). Blood MTBE values
from the two laboratories werehighlyand sig-
nificantly correlated (r= 0.91), whereas TBA
values were significantly but moderately cor-
related (r= 0.52).
Symptom questionnaire. A list of 42
symptoms associated with MTBE, solvent
exposure, anxiety (17), depression (18), and
breathing problems was used to assess symp-
toms during the exposure protocol (Table
1). Each symptom was rated on a scale from
0 (barely detectable/no sensation) to 100
(strongest imaginable), which was developed
by Green et al. (19) to approximate a ratio
scale. The questionnaire was completed four
times during the protocol session, and symp-
tom ratings were summed and averaged to
form a total symptom score and the follow-
ing symptom subscales: MTBE, anxiety,
depression, breathing, solvent (Table 1).
MTBE symptoms were associated with
MTBE exposure from the literature on gall-
stone dissolution, animal toxicology, and the
Alaskan studies (20). Although the literature
offers some logical basis for use ofa subset of
symptoms as MTBE-related, both the
Alaskan epidemiologic and gallstone studies
involved other concurrent exposure (e.g.,
sedatives for gallstone procedures), which
could contribute to the symptoms experi-
enced. In addition to symptoms, subjects
were also asked to rate the environment on a
1-5 scale for eight qualities such as lighting
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intensity, noise, and temperature (21). A
total environment score was computed by
summing and averaging these ratings each
time the questionnaire was given.
Odor questionnaire. The odor scale
assessed odor intensity and irritation on a
scale from 0 (barely detectable/no sensation)
to 100 (strongest imaginable) and pleasant-
ness (1 = verypleasant to 9 = veryunpleasant)
(22). The scales were administered at 5-min
intervals during the20-min session.
Neurobehavioral test. A computerized
divided-attention test of cognitive perfor-
mance, Performance On Line (POL) (23),
Tablet. Sym'ptomnquestloimaires:u"bcals8..
Symptom Manistaion
MTBE8 TThratirritation
Eye irritaton
Coughing
Nose irritation, dryness,
or--iitchig
Tireddrsleepy
Headache
Nasea.
AnUiley ..jitery
Shortofbreath
owus
Badtaste
Sneeze
Nasalcongetion
Stoma:'c'
Heartpalpitations
farringing
.lgcramps
Skinirritaion ordryness
Perspirng
LWarmtickling,
tingling, numb
Drowsy
Difficultyconcentrating
Chestpain
Fatigued
Backpain
Muscleorjointpain
'Ratng scale: 0 (hbe' ts d*et_beh sensiontto 100
(strongestimagiable). Ratingsued 1(low)to5(high).
was chosen because it has been shown to be
sensitive to the effects ofalcohol in repeated-
measures studies and because it is a comput-
erized driving simulation task that could be
useful to test the effects ofMTBE on cogni-
tive functions relevant to driving. This test
includes a central task in which the subject is
presented with two lanes oftraffic, divided by
a double yellow line. Four conditions ofhead
lights and tail lights appear on any one trial:
a) left lane, white head lights and right lane,
red tail lights; b) left lane, red lights and right
lane, white lights; c) left and right lane, red
lights; and a) left and right lane, white lights.
The subject is instructed to press the space
bar onlywhen condition aor asafe condition
exists. Additionally, a peripheral task requires
that the subject respond with one of four
arrow keys (up, down, left, right) in the
direction of the critical stimulus (octagon
shape representing a stop sign). Task difficul-
ty increases by adding to the number ofdis-
tracting stimuli in the peripheral display
usinga random assortment ofcircles, squares,
and triangles ofdifferent colors. The task has
five levels that progress in difficulty. The sub-
ject practices the first four levels in prepara-
tion for the fifth level, in which the subject
must respond to both central and peripheral
critical stimuli. After learning the task, 10 tri-
als of 45 displays are presented at the fifth
level. A composite performance score encom-
passes all ofthe responses related to the cen-
tral and peripheral tasks of the test and is
based on a weighted algorithm (23). This
score accounts for the speed and accuracy of
all responses and was the only score used for
analysis ofperformance.
Psychophysiologic measures. We used the
Flexcomp Biomonitoring System 1.51B
(Thought Technology Limited, Montreal,
Quebec, Canada) to collect heart and respi-
ration rate, surface electromyograph (EMG)
from the frontalis area, finger pulse volume,
and finger temperature as indicators ofphys-
iologic responses to the exposure conditions.
Cardiac data (16 samples/sec) were collected
using disposable EKG electrodes with one
electrode placed over the right mid-clavicular
area, one over the left mid-clavicular area
and the third placed just below the sternal
notch as the ground lead. EMG (16 sam-
ples/sec) was obtained from disposable elec-
trodes with the positive electrode positioned
approximately 2 cm over the right eye, the
negative 2 cm over the left eye, and the
ground electrode in the center of the fore-
head. This placement detects activity
throughout the facial area and is significantly
affected by emotional changes (24). Finger
temperature (1 sample/sec) was assessed
using a thermister and Flexcomp software,
and finger pulse volume (3 samples/sec) via
an LED photoplethysmograph and peak
detection software developed in our labora-
tory. The Criticare Systems Inc. Pulse
Oximeter End Tidal (POET) II (Waukesha,
WI) CO2 monitor was used to collect end-
tidal CO2 (31 samples/sec) and respiration
count through a nasal catheter and cannula.
End-tidal CO2 is a noninvasive measure that
is closely related to PaCO2 (25,26).
Delivery system. Approximately 70 mL of
the gasoline mixture was poured into a 100-
mL three-necked Pyrex flask. The two unused
necks were capped tightly to prevent evapora-
tion of the gasoline mixture. A length of
Teflon tubing was inserted into the center
neck of the flask and connected to an
adjustable stroke laboratory pump (model
V100; Fluid Metering, Inc., Oyster Bay, NY).
The pump consisted ofa piston (model HOO)
made from stainless steel encased in a plastic
cylinder and lined with a sintered carbon
liner. After passing through the pump, the
tubing containing the gasoline mixture passed
through a pulse dampener to suppress the
flow pulse. Once the pulse had been sup-
pressed, thegasoline mixture passed through a
capillary tubing to a Y-connecter on the top
ofa condenser column seated atop a 500-mL
three-necked flask placed within a 45°C heat-
ed water bath (#66648; Precision Scientific,
Chicago, IL). A fiberglass wick was placed at
the end ofthe capillary tubing and was used
to control dripping and delivery of gasoline
into the column. As the wick became saturat-
ed, a small drop of gasoline would drip
through the column, where a heated air
stream (4 L/min) would strip the volatile
components of the mixture from the drop
and deliver the vapor back up through the
column to the top of a Y-connector on the
condenser column, which was connected to
heated tubing at 243°C. The tubing (model #
LP212-4-50; Technical Heaters, Inc, San
Fernando, CA), with low-pressure Teflon
core and tin/copper overbraid, was connected
into the air delivery system of the controlled
environment facility (CEF) at the diffusers.
The system was designed to achieve a 15%
MTBE level of 1.7 ppm in the CEF. Further,
the delivery system would not vaporize the
entire gasoline droplet because such a scenario
would deliver compounds to the subject not
normallyinhaled bya commuter.
The water bath contained a 1/125 horse-
power submersible circulating pump (model
4182K22; McMaster-Carr, New Brunswick,
NJ), operating at 2.8 gal/min, connected to a
reflux condenser and a 500-mL three-necked
flask, which collected the heavier components
of the gasoline. The flask contained a ther-
mometer to ensure the temperature was con-
stant. An air line connected to a small air
pump (MEDO, Hanover Park, IL) was
placed into the neck of the flask to strip off
the more volatile constituents ofthe gasoline
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mixture and deliver vapors through the heat-
ed tubing at 4 L/min. The circulating pump
was used to drawwater from the heated water
bath and deliver it through the column. The
exposed glass Y-connector at the top of the
column was covered with glass wool and
wrapped with a heated tape (McMaster-Carr)
to ensure that the system was at a constant
temperature and that the vapors did not cool
before entering theheated tubing.
Gasoline mixture storage and handling.
Winter blend gasoline (i.e., with no
oxygenates) (Sunoco Custom Blends, Phila-
delphia, PA) was stored in a tightly sealed
55-gal drum in an enclosed external storage
facility. It was siphoned into a clean 3.9-L
Qorpak amber safety-coated container
(Fisher Scientific, Pittsburgh, PA) as needed
using a Teflon-lined manual siphon. The
same gasoline was used for the nonoxygenat-
ed gasoline exposure samples and to make
the two blends ofoxygenated fuels: gasoline
without oxygenate was mixed with 15%
(vlv) MTBE (1.7 ppm in air) (Mallinckrodt
Baker, Paris, KY) to simulate the winter
blend of gasoline, and with 1 1% (vlv)
MTBE (1.1 ppm in air) to simulate the con-
centration of MTBE added to a reformulat-
ed gasoline. Both blends were stored in
separate, tightly sealed glass jars and kept in
a cold room at 40C. Before use, a blend was
allowed to equilibrate to room temperature.
Vapor monitoring. A gas chromatograph,
with a DB-VRX column J&W Scientific,
Folsom, California) initially heated to 350C,
was used to determine the MTBE concentra-
tion within the facility approximately 8 min
into the exposure session. The temperature of
the column was held for 10 min and
increased at a rate of5°C/min to a final tem-
perature of150°C, where itwas again held for
10 min. The injector anddetector were main-
tained at 200°C. The MTBE samples were
collected in sorbant traps made of stainless
steel tubes (0.5 cm id x 8.8 cm; Perkin-
Elmer, Inc., Norwalk, CT) and were packed
with Carboxen 569 (Supelco Inc., Bellefonte,
Pa). The trap was filled with 0.6 g Carboxen
569 and held inplacebyglass wool andgauze
on both ends. Each trap was conditioned in
an oven for 6 hr at 3400C. All conditioned
traps were sealedwith aTeflon cap andstored
in a desiccator before use. The absorbed
MTBE was transferred to acapillary gas chro-
matograph (5890; Hewlett-Packard) with a
DB-5 capillary column J&W Scientific) for
analysis using an automated thermal desorp-
tion system (model ATD-400; Perkin-Elmer,
Inc.). Quantification was completed using a
Hewlett-Packard 5970 mass selective detec-
tor. The total hydrocarbon concentration in
the CEF, evaporated from gasoline, was 33 ±
0.5 ppm, measured and reported as methane
by a total hydrocarbon analyzer (model
23-500; GOW-MAC, Lehigh Valley, PA).
The sample pressure setting on the total
hydrocarbon analyzer was maintained at 2.5
psi, and the air and fuel pressure settings were
maintained at 25 psi and 7.0 psi, respectively.
There was a consistent relationship between
the total hydrocarbon level and the level of
MTBE present in gasoline. Thus, the total
hydrocarbon levels were used as a continuous
indicator ofMTBE levels. This resultwas ver-
ified by analyzing air in the CEF for MTBE
by gas chromatography in a grab sample. A
final verification ofthe MTBElevel during an
individual exposure was the analysis ofa sam-
ple of the average level of MTBE over the
entire session. For gasoline with 15% MTBE,
the average CEF concentration was 1.7 ppm,
and for gasoline with 11% MTBE, the aver-
age CEF concentration was 1.1 ppm.
Controlled environmentfacility. The
facility is a 7.3 ft (height) by 13.5 ft (width)
by 9 ft (depth) stainless-steel room in which
air flow, temperature, and humidity are var-
ied and controlled. The facility was operated
at 70 ± 1°F during each exposure session.
The relative humidity range was maintained
at 45 ± 2% for each exposure session. Air
flow was maintained between 650 and 700
cubic feet per minute (cfm), and the facility
was operated under negative pressure of 0.1
inches ofwater. The nonrecirculated air sup-
ply passed through a sequence ofcondition-
ing processes, which included air cooling and
heating, humidification and dehumidifica-
tion, and filtration through 12 carbon filters
and 1 HEPA filter. The air supply entered
the facility through two diffusers in the
ceiling and exited through the perforated
stainless-steel floor to exhaust vents. Air con-
centrations for exposures were maintained by
constant injection ofcompounds into the air
supply, which flows through the room with-
out recirculation. The gasoline mixture was
introduced into the air supply by means of
an evaporation delivery system and was well-
mixed before entering the facility to achieve a
uniform concentration throughout its vol-
ume. The desired concentration within the
CEF was attained within 5 min. To ensure
that a uniform concentration was maintained
after delivery of the mixture into the cham-
ber, a 12-inch, three-speed oscillating fan was
kept running on low speed during an expo-
sure session. Levels of total hydrocarbons
were continuously monitored remotely to
ensure that experimental levels were main-
tained for the duration ofthe session. Study
participants entered the facility through an
air lockwhich had two doors; one opened to
the outer room and the other into the facili-
ty. Throughout the experimental exposure,
subjects were observed through a two-way
window and contact was maintained via
an intercom.
Procedure
For the orientation visit, subjects reported to
the clinical center, where they gave informed
consent in accordance with standard
Institutional Review Board procedures. A
complete medical history, a physical exami-
nation, and an EKG were performed on each
subject. To reduce anticipatory anxiety and
practice effects on the neurobehavioral task,
subjects learned to use the POL driving sim-
ulation software by performing levels 1-5.
Subjects then completed an unblind baseline
session in the CEF to reduce initial anxiety
and to familiarize them with the procedures
and surroundings. All sessions including the
unblind orientation session occurred in the
morning to control for circadian rhythm
variation and followed the same procedures
as outlined below.
Exposure sessions were double blind.
Previous research to test the ability of SRSs
and controls to discriminate gasoline alone
from gasoline with 15% MTBE and from
gasoline with 15% MTBE and a re-odorant
found that subjects from both groups per-
formed no better than chance. Subjects were
asked to identify two mixtures as "same" or
"different" when the mixtures were present-
ed in pairs of standard sniff bottles (27).
Therefore, based on this inability to distin-
guish gasoline from gasoline with 15%
MTBE, no re-odorant was added to the
exposure conditions to "mask" the odor of
MTBE. Moreover, we assumed that expo-
sure conditions were blind to subjects, and
this assumption was also tested by asking
subjects to guess the exposure condition.
SRS subjects were randomly assigned to
an order ofexposure, and their demographi-
cally matched controls were assigned to the
same order. For each exposure visit, subjects
were admitted by a nurse who ascertained
that theydid not have a viral illness, were not
pregnant, and had not taken medications
that would disallow participation. Subjects
had EKG electrodes attached, completed 10
trials of POL at level 5 as baseline neurobe-
havioral performance, and were escorted to
the CEF. The subject was then instructed
about safetyprocedures andlocation ofemer-
gency exits, given a Tyvek suit to protect
clothing, and electrodes for frontalis EMG
recording, finger pulse volume, and finger
temperature were attached by the experi-
menter. A sterile, non-reusable cannula for
end-tidal CO2 recordingwas inserted approx-
imately 1/4 inch inside the nose and held in
place with surgical adhesive tape. The subject
was then seated in a comfortable, nonredin-
ing chair with the computer keyboard and
monitor in front ofhim or her on a stainless-
steel table, and the experimenter left to begin
the session. The experimenter constantly
observed the subject through a one-way
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window, and an intercom was used for com-
munication. The subject completed the first
symptom questionnaire and was then asked
to sit quietly, relax, breathe through the nose,
and keep eyes open for the next 20 min.
Throughout this period, the subject viewed
the computer monitor, where a vigilance task
randomly displayed bars on the screen and a
tone sounded occasionally to maintain the
subject's attention. The subject was instruct-
ed to keep a mental count of the bars and
then report the total number when asked at
the end of the experimental session.
Additionally, during this 20-min period, the
subject heard a warbling sound every 5 min
afterwhich an odor surveywas completed.
All sessions began with a 5-min relax-
ation period, during which baseline psy-
chophysiologic measures were taken. For
those sessions in which exposure to gasoline
with or without MTBE occurred, exposure
began after the 5-min relaxation or baseline
period and lasted for 15 min (Figure 1). The
subject was not informed when the exposure
began. Therefore, the only exposure cue was
perceived odor. During the 15-min exposure
period, the subject sat quietly and counted
the bars on the monitor. Immediately after
exposure, psychophysiologic measurements
were discontinued, and the subject was
instructed to remove all the monitoring leads
to which he or she was connected. The sub-
ject was instructed to complete another
symptom questionnaire and then performed
10 trials ofPOL at level 5. Before leaving the
CEF, the subject was asked to guess the
exposure condition from four possible choic-
es (no exposure; gasoline with no MTBE,
gasoline with low MTBE, gasoline with high
MTBE), removed the Tyvek suit, and was
escorted to the clinical center. The subject
completed a postexposure symptom ques-
tionnaire, performed 10 trials of POL at
level 5, and filled in another symptom ques-
tionnaire just before leaving for the day.
Each visit lasted approximately 3 hr.
Hypotheses and Statistical Analysis
Symptoms, neurobehavioral performance,
and psychophysiologic variables were analyzed
as separate variable groups. Because data for
each ofthese variables sets were frequently not
normally distributed, permutation tests were
used to assess group differences. For example,
approximately 50% of the ratings for symp-
tom variables were zero.
Permutation (or randomization) tests fall
into the same general class ofstatistical meth-
ods as bootstrapping, resampling techniques
(28). Permutation tests enumerate all possible
permutations of the data permissible under
the null hypothesis, and examine the observed
sample test statistic in the context ofthis per-
mutation distribution. They do not assume
normality. For example, suppose we had two model, with group as a between-subjects fac-
samples ofsize 5 each, and we measured each tor and exposure and time as within-subjects
observation on some numeric response vari- factors, was used. Lack ofsphericity was cor-
able; ifwe could assume that in the popula- rected forwith a Hyunh-Feldt correction.
tions from which these samples were drawn The hypothesis for symptom data was
that the variable is normally distributed, then that relative to controls, SRSs would report
an independent-groups t-test would be an more symptoms in each ofthe exposure con-
appropriate statistical test. If we cannot ditions (i.e., gasoline, gasoline with 11%
assume normality, then a t-test is inappropri- MTBE, gasoline with 15% MTBE). To test
ate with this sample size. (A nonparametric this hypothesis, baseline symptom scores (1-5
test is a common alternative, but is less pow- min) were subtracted from postexposure
erful than the parametric test.) Under the null symptom scores for each subject; a difference
hypothesis ofno group mean difference, it is score between exposure conditions ofthe pos-
equally likely that a particular score would texposure/baseline difference scores was com-
occur in one group as in the other group. puted as follows using gas with 15% MTBE
That is, under the null hypothesis, there really versus dean airas an example:
is one population. The division ofthe obser- N(PostexposureGl5(1 N) -BaselineGl5(I N)
vations into two groups is simply random if N'
the null hypothesis is true. The null hypothe- N
sis is examined by determining how unusual ii N(PostexposureCA() N) -BaselineCA(1 N))
the mean difference observed actually is by N
generating all possible permutations of the
data: all possible ways of dividing these 10 These differences were then compared
observations into two groups of 5 each (i.e., between groups (SRSs/controls) for all expo-
252 possible divisions). For each ofthese 252 sure condition pairs. A dose-response reduc-
permutations, the observed value of the test tion in neurobehavioral performance was
statistic is calculated (t-statistic). The p-value hypothesized for SRSs relative to controls,
or the probability ofobserving a test statistic with the most significant reduction occurring
as extreme or more extreme under the null in the gasoline with 15% MTBE condition.
hypothesis is calculated. For example, suppose Baseline POL was subtracted from postexpo-
that the tobserved was the largest t-statistic in sure POL; the difference between all pairs of
the distribution of 252 t-statistics generated exposure conditions ofthe baseline/postexpo-
from permutations ofthe data; theprobability sure difference was compared (see above
of observing a t-statistic as extreme or more equation) between SRSs and controls to
extreme than the one observed would be assess neurobehavioral effects.
1/252, or 0.004. Because this P-value is less We evaluated two hypotheses for the
than the predetermined significance level of psychophysiologic variables. First, ifsubjects
0.05, the null hypothesis is rejected. had a response to the odor of MTBE, such
When total scores for symptoms and as that seen for dental odors (15), significant
neurobehavioral performance were used, cor- changes in psychophysiologic indicators
rections for multiple comparisons were not (e.g., heart rate, respiration rate) would be
made. However, ifthe overall total score was seen shortly after exposure onset when the
significant, we analyzed subscale scores and odor ofthe exposure was initially perceived.
applied the Bonferroni correction for multi- Therefore, for every psychophysiologic vari-
ple comparisons. For odor ratings, a mixed able for each subject, the average baseline
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Figure 1. Protocol time line.
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values (no-exposure) at 3 and 4 min of the
baseline period (1-5 min) were subtracted
from the average values measured at 6, 7,
and 8 min (early exposure) immediately fol-
lowed the onset of the exposure period
(6-20 min). Second, if MTBE in gasoline
had a direct physiologic effect, changes in
physiologic measures would be seen later in
exposure when MTBE was measurable in
blood. Therefore, for each subject, the aver-
age of 3 and 4 min was used as a baseline
(no-exposure) and was subtracted from min
18, 19, and 20 (late exposure) at the end of
the exposure. We chose min 18, 19, and 20
because they would reflect maximum body
burden accumulated by a subject after 15
min of exposure. Difference scores between
exposure conditions (e.g., gasoline with 15%
MTBE minus clean air) were computed
from the within-exposure condition differ-
ence scores for each subject and were then
compared for all exposure condition pairs.
Tests for symptoms, POL, and psy-
chophysiologic responses in min 6, 7, and 8
were one-tailed with a significance level ofp
< 0.05 due to the hypothesis that SRSs
relative to controls would show the greatest
effects of exposure to gasoline with 15%
MTBE. Directionality for baseline versus
late exposure psychophysiologic responses
was not hypothesized, and therefore, two-
tailed tests were conducted for these
comparisons.
A series ofpermutation tests to compare
changes in the symptoms, neurobehavioral
performance, and psychophysiologic vari-
ables were conducted between the exposure
conditions clean air versus gasoline with
15% MTBE; gasoline versus gasoline with
15% MTBE; and gasoline with 1 1% MTBE
versus gasoline with 15% MTBE. The ques-
tions addressed with these comparisons were;
Does gasoline with 15% MTBE produce
any significant effect when the maximum
possible difference in exposures is compared,
(i.e., relative to clean air)? and Is MTBE at
15% in gasoline producing a significant
effect beyond that seen with exposure to
gasoline or gasoline with 11% MTBE? In
addition, the remaining exposure compar-
isons were conducted, (i.e., clean air versus
gasoline, clean air versus gasoline with 110%
MTBE; gasoline versus gasoline with 1 1%
MTBE). Finally, to assess differences in the
distribution in guessing accuracy for the
SRSs and controls, we used the Cochran-
Mantel-Haenszel (CMH) Type II statistic.
Results
Blood levels ofMTBE and TBA. The results
obtained for MTBE blood levels for all
subjects for the four sets of exposure condi-
tions are shown in Table 2. For both groups,
the preexposure MTBE levels in blood
averaged < 0.5 ng/mL. For all subjects (con-
trol and SRS), paired t-tests were used to
contrast difference scores (post- minus preex-
posure blood levels) of MTBE in blood
between all possible pairs ofexposure condi-
tions. As shown in Table 3, the gasoline with
15% MTBE and gasoline with 11% MTBE
exposure conditions produced significantly
greater MTBE blood levels than clean air and
gasoline alone. Although TBA was also sig-
nificantly higher for gasoline with 15%
MTBE and gasoline with 1 1% MTBE expo-
sures relative to clean air and gasoline expo-
sures, no significant difference in TBA was
shown between gasoline with 1 1% MTBE
and gasoline with 15% MTBE. When differ-
ence scores for MTBE and TBA levels were
compared between SRSs and controls for
both the gasoline with 15% MTBE and
gasoline with 11% MTBE exposure condi-
tions, no significant differences were
observed. Thus, SRSs and controls were not
different in their uptake or metabolism of
MTBE in blood during the period covered
by the experiment (Table 3).
Symptom questionnaire. Initially, total
symptom scores at baseline in each exposure
condition were compared between SRSs and
controls (Table 4). Figure 2 reveals that
SRSs reported significantly more total symp-
toms than controls during every exposure
condition. Thus, SRSs were more sympto-
matic than controls regardless of exposure.
The primary question of the present study,
however, was to determine whether the SRSs
responded differently from controls when
exposed to gasoline, gasoline with 110%
MTBE, or gasoline with 15% MTBE.
Therefore, total symptom difference scores
(postexposure minus baseline) for each expo-
sure condition were compared to every other
exposure condition by subtracting the differ-
ence score from one exposure condition
from the difference score of the comparison
exposure condition (Tables 5 and 6).
SRSs reported significantly more total
symptoms than controls when both the
clean air and the gasoline with 110% MTBE
condition were contrasted to gasoline with
15% MTBE (p < 0.02 for both contrasts);
although nonsignificant, SRSs tended to
report more total symptoms than controls in
the gasoline with 15% MTBE exposure rela-
tive to the gasoline exposure condition (p
< 0.08). Total symptom scores were not sig-
nificantly different between SRSs and con-
trols when air versus gasoline, air versus
gasoline with 1 1% MTBE, and gasoline ver-
sus gasoline with 11% MTBE exposures
were contrasted (Table 6).
For those total symptom contrasts that
were significantly different, secondary per-
mutation analyses were used to contrast
symptom subscales. Tables 7 and 8 show all
subscale contrasts. For both the clean air ver-
sus gasoline with 15% MTBE and gasoline
with 1 1% MTBE versus gasoline with 15%
MTBE contrasts, the MTBE, anxiety, and
solvent subscales (as defined in Table 1) were
significantly higher for SRSs than for con-
trols, but the remainder of symptom sub-
scales were not significantly different between
the two groups. Moreover, the environmen-
tal quality score for air versus gasoline with
15% MTBE was significantly higher for
SRSs than for controls. However, when the
Bonferroni correction for multiple compar-
isons was made (0.05/6; p < 0.008), the only
subscale contrast that remained significant
was that for the MTBE subscale in the gaso-
line with 11% MTBE versus gasoline with
15% MTBE contrast.
Neurobehavioral measures. For SRSs rel-
ative to controls, no significant differences
were noted for any of the above contrasts
using the composite score of the POL
(Tables 9 and 10).
Table 2. MTBE and TBA blood levels for all sub-
jects in each exposure condition [mean (SE)].
Preexposure Postexposure
(ng/mL) (ng/mL)
MTBE
Clean air 0.18 (0.04) 0.13 (0.02)
Gasoline 0.23 (0.05) 0.22 (0.06)
Gas/i 1% MTBE 0.08 (0.02) 1.23 (0.09)
Gas/15% MTBE 0.11 (0.01) 1.75(0.10)
TBA
Clean Air 0.80 (0.21) 0.86 (0.23)
Gasoline 0.86 (0.22) 1.04 (0.24)
Gas/11% MTBE 1.20 (0.20) 2.34(0.20)
Gas/i 5% MTBE 1.22 (0.19) 2.63 (0.21)
Table 3. Blood levels [mean (SE)] of MTBE and TBA in SRSs versus controls before and after exposure to
different levels of MTBE in gasoline.
Within condition
Preexposure Postexposure differencea
SRS Control SRS Control SRS Control p
Gas/1 1% MTBE
MTBE(ng/ml) 0.11(0.06) 0.06(0.01) 1.15(0.13) 1.28(0.12) 1.04(0.12) 1.22(0.12) 0.35
TBA (ng/mL) 1.81(0.49) 0.87(0.11) 2.69 (0.36) 2.14 (0.24) 0.88 (0.41) 1.27 (0.22) 0.37
Gas/15% MTBE
MTBE(ng/mL) 0.15(0.02) 0.09(0.01) 1.76(0.11) 1.75(0.14) 1.61(0.11) 1.66(0.14) 0.78
TBA(ng/mL) 1.53 (0.35) 1.03 (0.22) 2.95 (0.45) 2.44 (0.21) 1.42 (0.19) 1.41(0.19) 0.98
"See "Hypotheses and Statistical Analysis" for calculations.
VOLUME 1081 NUMBER 81 August 2000 * Environmental Health Perspectives 758Articles . Self-reported sensitivity to MTBE exposure
Psychophysiologic variables. The initial
set of permutation analyses compared psy-
chophysiologic changes from baseline (no
exposure) to early exposure (min 6, 7, and 8)
between all pairs ofexposure conditions. No
significant differences between SRSs and
controls were noted for any of the contrasts
ofthe psychophysiologic variables. The same
analyses were repeated comparing changes
from baseline (no exposure) to late exposure
(min 18, 19, and 20) contrasting all pairs of
exposure conditions. No significant differ-
ences between exposure conditions were
observed for heart rate, respiration rate, fin-
ger pulse volume, or finger temperature.
However, when clean air was contrasted to
gasoline and to gasoline with 15% MTBE,
end-tidal CO2 was significantly higher at
postexposure for SRSs relative to controls
(not shown). Examination of the end-tidal
CO2 records revealed that some readings
were due to incomplete breaths or sniffs dur-
ing exhalation. When the end-tidal readings
associated with sniffs, which do not reflect
arterial CO2, were removed, end-tidal CO2
was no longer significantly different between
SRSs and controls in the clean air versus
gasoline 15% MTBE contrast. End-tidal
CO2 remained significantly different
between gasoline and clean air. Because this
finding was not an effect ofMTBE, howev-
er, it was not regarded as meaningful.
EMG readings were significantly different
between SRSs and controls for all contrasts
except clean air versus gasoline with 15%
MTBE. However, EMG readings for SRSs
increased significantly relative to controls in
the gasoline with 11% MTBE, whereas EMG
readings increased significantly for controls
relative to SRSs in the gasoline with 15%
MTBE condition. This pattern of EMG
results did not support a consistent effect of
Table 4. Permutation analysis: total baseline
symptoms before each exposure condition in
SRSs versus controls (mean ± SD).
Baseline SRS Control p
Clean air 14.3 ± 23.9 1.6 ± 2.7 0.002
Gasoline 10.2 ± 15.7 1.4 ± 2.7 0.0009
Gas/i 1% MTBE 14.7 ± 23.3 1.3 ± 2.0 0.002
Gas/i5% MTBE 18.8 ± 32.8 1.6± 2.7 0.0001
MTBE for either group and suggests random
fluctuation between exposure conditions and
subject groups. In conclusion, SRSs did not
showsignificant psychophysiologic changes in
response to the odor of the exposure condi-
tions or in response to biologically detectable
levels ofMTBE in blood.
ExYposure guessing. To assess the effect of
subjects' awareness of the exposure condi-
tions, accuracy ofsubjects' guessing was ana-
lyzed. Initially, a kappa statistic was computed
to assess overall accuracy [K = 0.16; 95% con-
fidence interval (CI), 0.049 - 0.294]. This
revealed that subjects were significantly better
than chance at guessing the exposure condi-
tion. However, examination of performance
revealed that subjects' accuracy was only
slightly better than chance (chance guessing
= 31/124 guesses; 46/124 correct guesses
made). To explore whether guessing accura-
cy was primarily due to the ability to distin-
guish clean air from the gasoline and MTBE
exposure conditions, the kappa statistic cal-
culation was repeated without the clean air
condition guess and was not significant (K =
-0.01; 95% CI, -0.15-0.12). Therefore, it
appears that the ability to distinguish
between clean air and any other exposure
condition was responsible for most of the
correct guessing observed. In fact, kappa was
significant when guesses made during clean
air were compared to guesses for all other
exposure conditions (K = 0.58; 95% CI,
0.40-0.75). That is, the accuracy rate for
clean air was 106 out of 124 guesses. This
finding suggests that while subjects generally
knew when they were being exposed to
chemical mixtures rather than to clean air,
they were unable to distinguish gasoline
exposure from gasoline with MTBE at 11%
(gasoline with low MTBE) or 15% (gasoline
with high MTBE).
In addition to computation ofthe overall
guessing accuracy, the possibility that SRSs
and controls differed in guessing accuracy
was tested. To conduct this test, the number
of correct guesses was computed for each
subject. The CMH type II statistic revealed
no differences in guessing accuracy between
the SRSs and controls (mean SRS = 1.66;
mean control = 1.37; p < 0.30). Therefore,
SRSs were no more accurate than controls in
correctly identifying the exposure condition.
Overall, 79% (19/24 guesses) ofSRSs report-
ed exposure to gasoline with MTBE when
they were, in fact, exposed to gasoline with
either 11% or 15% MTBE. However, their
accuracy in discerning whether they were
exposed to 11% or 15% MTBE in gasoline
was lowest for gasoline with 15% MTBE
(42% accuracy for 11% MTBE; 25% accura-
cy for 15% MTBE). Similar accuracy rates
were seen for controls, with a 71% (27/38
guesses) overall accuracy rate for determining
that MTBE was present in gasoline. Again,
controls were more accurate in guessing that
MTBE was present at 11% than at 15%
(53% accuracy for 11% MTBE; 21% accura-
cy for 15% MTBE). Furthermore, 75%
(9/12 guesses) of the SRSs and 79% (15/19
guesses) ofcontrols thought they were being
exposed to gasoline with MTBE at 11% or
15 % when they were actually exposed to
gasoline alone. Table 11 gives all percentages
for guessing accuracy.
Odorratings. To analyze the odor ratings
completed within each exposure condition,
mixed model analyses of variance were used
with group (SRS versus control) as a
between-subjects factor and exposure (clean
air, gasoline, gasoline with 11% MTBE,
gasoline with 15% MTBE) and time (min 5,
10, 15, and 20) as the within-subjects factors.
Separate analyses were conducted for each of
Table 5. Total symptom scores [mean (SEfl at baseline and postexposure for SRSs and controls in each
exposure condition.
Clean air
Gasoline
Gas/11% MTBE
Gas/i 5% MTBE
Baselinea
SRS Control
14.3 (6.9) 1.6 (0.6)
10.2(4.5) 1.5(0.6)
14.7 (6.7) 1.3 (0.5)
18.8(9.5) 1.6 (0.6)
Postexposureb
SRS Control
32.0 (17.3) 5.6 (2.2)
28.5 (7.5) 6.9 (2.7)
32.1 (14.2) 8.8(5.5)
58.5 (25.7) 7.5(2.7)
Within-condition
differencec
SRS Control
17.5(10.5) 4.0 (1.9)
18.3 (4.8) 5.4 (2.5)
17.4(8.9) 7.5 (5.3)
39.7 (17.5) 5.9 (2.6)
-60
CS 5
.5030
.
A 10 I=l
11% MTBE 15%MTBE
Figure 2. Total symptom response to exposure
conditions.
aBaseline = mins 1-5. bPostexposure = immediately following 20-min exposure period. cSee'Hypotheses and Statistical
Analysis" for calculations.
Table 6. Total symptom scores [mean(SE)] at baseline and postexposure for SRSs and controls: permuta-
tion analyses of difference scores between exposure conditions.
SRS Control p
Gas/i 5% MTBE -clean air , 22.04(10.23) 1.83(1.38) 0.02
Gas/15% MTBE-gasoline 21.54(16.90) 0.46(1.66) 0.08
Gas/15% MTBE -gas/11% MTBE 22.40 (10.97) -1.69 (4.13) 0.02
Gasoline -clean air 0.50(10.83) 1.37 (2.04) 0.60
Gas/i 1% MTBE -clean air -0.36 ( 6.12) 3.53 (4.63) 0.66
Gas/i 1% MTBE -gasoline -0.86 (10.18) 2.15(2.98) 0.63
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exposure was seen for intensity and irritation
ratings but not for pleasantness, and a signifi-
cant time effect was observed for all three rat-
ings. Because the exposure X time interaction
was significant for intensity and pleasantness,
this interaction was graphed and interpreted.
For all three qualities, ratings changed less
over time for clean air exposure than for any
ofthe other exposures. Differences in ratings
Table 7. Subscale symptom scores [mean (SE}] at baseline and postexposure for SRSs and controls in
each exposure condition.
Within-condition
Baselinea Postexposureb differencec
SRS Control SRS Control SRS Control
MTBE
Clean air 4.6 (1.9) 0.6(0.3) 10.1 (4.8) 2.3(0.8) 5.5 (3.0) 1.7 (0.7)
Gasoline 2.8(0.7) 0.6 (0.2) 10.7 (2.4) 2.8 (1.2) 7.9 (2.0) 2.2 (1.2)
Gas/i1% MTBE 3.8(1.6) 0.5(0.2) 9.2 (2.5) 3.5(1.6) 5.4(1.8) 2.9 (6.2)
Gas/15% MTBE 5.3(2.3) 0.5 (0.2) 18.5 (6.0) 2.7 (0.8) 13.2 (4.7) 2.2 (0.8)
Anxiety
Clean air 1.4(0.7) 0.2 (0.1) 4.5 (2.7) 1.1 (0.7) 3.1 (2.1) 1.0(0.7)
Gasoline 0.3 (0.3) 0.0 (0.0) 5.3 (1.9) 0.6 (0.3) 5.0 (1.7) 0.6 (0.3)
Gas/i1% MTBE 1.3(0.5) 0.1 (0.1) 3.9 (2.3) 1.2 (1.0) 2.6 (2.2) 1.1 (1.0)
Gas/15% MTBE 2.8 (1.9) 0.6(0.4) 10.8 (5.9) 1.3 (0.6) 8.1 (4.3) 0.7 (0.6)
Depression
Clean air 1.8(0.6) 0.4(0.2) 6.1 (3.3) 0.4(0.3) 4.3 (3.3) -1.2 (0.3)
Gasoline 5.0 (3.7) 0.4(0.4) 4.0 (1.5) 1.4(0.6) -1.0 (2.7) 1.0(0.5)
Gas/i 1% MTBE 4.2 (2.0) 0.0 (0.0) 7.8(3.3) 1.1 (0.8) 3.6 (2.1) 1.1 (0.8)
Gas/15% MTBE 5.0(2.7) 0.1 (0.1) 13.3 (5.7) 0.9(0.5) 8.3(4.3) 0.8(0.5)
Breathing
Clean air 3.5(3.3) 0.0 (0.0) 4.8 (3.7) 0.5 (0.4) 1.3 (0.6) 0.5 (0.4)
Gasoline 0.1 (0.1) 0.0 (0.0) 2.6 (1.7) 0.2 (0.2) 2.5(1.7) 0.2 (0.2)
Gas/11% MTBE 2.0(1.6) 0.1 (0.1) 4.4(4.4) 1.6 (1.4) 2.4(2.9) 1.5(1.4)
Gas/15% MTBE 1.5(1.5) 0.1 (0.1) 5.2 (4.8) 1.1 (0.9) 3.8(3.3) 1.0(0.9)
Solvent
Clean air 2.9(1.3) 0.4 (0.2) 6.5 (3.2) 1.3 (0.4) 3.6 (1.8) 0.9(0.3)
Gasoline 2.1 (0.7) 0.4(0.1) 5.9(1.4) 1.7 (0.6) 3.8(0.9) 1.4(0.6)
Gas/i1% MTBE 3.5(1.7) 0.5(0.2) 6.8 (2.8) 1.5(0.8) 3.3 (1.5) 1.0(0.7)
Gas/15% MTBE 4.2(2.4) 0.4(0.2) 10.7 (4.7) 1.6(0.5) 6.5(2.6) 1.2 (0.4)
Environment
Clean air 2.8(0.2) 2.8(0.1) 2.8 (1.9) 2.9 (0.1) 0.0 (0.1) 0.1 (0.0)
Gasoline 2.7 (0.1) 2.9 (0.1) 3.3(0.2) 3.0 (0.1) 0.6 (0.1) 0.1 (0.1)
Gas/i1% MTBE 2.6(0.1) 2.8 (0.1) 3.2 (0.1) 3.1 (0.1) 0.6 (0.1) 0.3 (0.1)
Gas/15% MTBE 2.6(0.1) 2.8(0.1) 3.2(0.2) 3.1 (0.1) 0.6(0.1) 0.3 (0.0)
aBaseline = min 1-5. bPostexposure = immediately following 20 min exposure period. cSee "Hypotheses and Statistical
Analysis" for calculations.
Table 8. Subscale symptom scores [mean (SE)] at baseline and post-exposure for SRSs and controls: per-
mutation analysis of difference scores between exposure conditions.a
SRS Control p
MTBE
Gas/15% MTBE -clean air 7.64(4.06) 0.53(0.64) 0.02
Gas/15% MTBE -gas/11% MTBE 7.74(3.96) -0.75(1.40) 0.001a
Anxiety
Gas/15% MTBE -clean air 4.97 (2.56) -0.26 (0.34) 0.009
Gas/15% MTBE -gas/i1% MTBE 5.42 (2.67) -0.39 (0.89) 0.02
Depression
Gas/15% MTBE - clean air 4.03 (2.79) 0.79 (0.58) 0.11
Gas/15% MTBE -gas/i1% MTBE 4.72 (3.40) -0.26 (0.88) 0.08
Breathing
Gas/15% MTBE -clean air 2.50 (3.14) 0.46 (0.53) 0.34
Gas/15% MTBE -gas/i1% MTBE 1.35 (0.98) -0.53 (0.54) 0.08
Solvent
Gas/15% MTBE - clean air 2.90 (0.16) 0.32 (0.29) 0.03
Gas/15% MTBE-gas/11% MTBE 3.16(1.63) 0.24(0.59) 0.05
Environment
Gas/15% MTBE -clean air 0.53 (0.16) 0.25 (0.06) 0.04
Gas/15% MTBE -gas/11% MTBE -0.04(0.08) 0.01 (0.10) 0.77
fBonferroni correction (0.05/6; p<0.0081.
of intensity and pleasantness between time 1
(ratings before exposure) and the remainder
of the ratings during the gasoline, gasoline
with 11% MTBE, and gasoline with 15%
MTBE were largely responsible for the signif-
icant exposure x time interaction for both
groups. Although the interaction (group x
exposure x time) was nonsignificant, the
SRSs showed a steady increase in irritation
over time for the gasoline with 15% MTBE
condition, which was not as evident for the
gasoline or gasoline with 11% MTBE expo-
sure conditions or for the controls. The same
was not true for intensity ratings, which
appeared to increase when exposure began
and remained at approximately the same level
for the remainder of the exposure period for
both groups. Although the exposure x time x
group interaction was not significant for
pleasantness (p < 0.06), pleasantness changed
less over time in all exposure conditions for
controls relative to SRSs.
Discussion
Exposure to gasoline with 15% MTBE result-
ed in significantly more symptoms among
SRSs relative to controls than did exposure to
clean air or to gasoline with 11% MTBE. In
addition, SRSs reported significantly more
symptoms than controls during the baseline
period preceding all exposure conditions, sug-
gesting heightened sensitivity, regardless of
exposure, among this group. It is interesting
to note that TBA levels were somewhat high-
er for the SRSs than for controls before expo-
sure to gasoline with 11% MTBE and gaso-
line with 15% MTBE (Table 3) but not
before exposure to gasoline or to clean air
(not shown). This suggests that before at least
two of the exposure conditions, SRSs were
exposed at some time during the previous
week to MTBE. However, the differences in
TBA between SRSs and controls were notsig-
nificant and were not significantly associated
with baseline symptom scores. Therefore, the
preexposure difference in TBA probably does
not account for baseline differences in symp-
toms. Although SRSs also reported more
symptoms than controls when exposed to
gasoline with 15% MTBE relative to gasoline
alone, this difference was not statistically sig-
nificant. Moreover, no significant differences
were observed when symptoms in response to
gasoline with 11% MTBE were compared to
clean air or to gasoline alone. Therefore, the
present results do not support a dose response
to MTBE exposure. Moreover, analysis of
symptom subscales did not confirm the
symptom specificity for MTBE exposure sug-
gested by the epidemiologic literature.
Despite increased symptoms during exposure
to gasoline with 15% MTBE, SRSs were not
impaired relative to controls in overall perfor-
mance of a driving simulation task, nor did
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the following odor ratings completed at each
point in time: irritation, intensity, and pleas-
antness. Table 12 shows the results of these
analyses. The group effect was significant for
irritation and intensity and approached sig-
nificance for pleasantness, with the SRSs
reporting more irritation, intensity, and less
pleasantness than controls over all exposures
and time points. A significant main effect of
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they show significant psychophysiologic
responses early or late in the exposure period.
Thus, controlled exposure to gasoline with
15% MTBE, while producing more symp-
toms, did not cause impaired performance or
psychophysiologic changes.
The present study also supports the re-
odorant study (217) finding that the majority
ofsubjects were unable to discriminate expo-
sure to gasoline from exposure to gasoline
with MTBE. Thus, subjects were indeed
blind to the specific exposure conditions, and
changes in symptoms could not be attributed
to either response bias due to awareness of
the exposure condition and/or anxiety in
response to odor. First, neither SRSs nor
controls were accurate in identifying specific
exposure conditions. Subjects were most
accurate in distinguishing clean air from
chemical exposures. However, neither SRSs
nor controls were able to distinguish whether
MTBE was present at 11% or 15%; and a
Table 9. Composite score [mean(SE)] Performance on Line forSRSs and controls in each exposure condition.
Baseline
SRS Control
Clean air 92.9(10.4) 101.7 (4.5)
Gasoline 88.0 (8.4) 103.2(5.1)
Gas/11% MTBE 94.9(8.1) 101.2(4.7)
Gas/15% MTBE 84.7 (9.5) 101.0(4.3)
&See "Hypotheses and Statistical Analysis" for calculations.
Postexposure
SRS Control
99.6 (7.1) 104.4(4.6)
88.4(8.6) 104.9 (4.5)
94.4(7.0) 103.9(4.5)
79.4(11.7) 102.5(4.0)
Within-condition
differencea
SRS Control
6.7 (12.1) 2.7 (1.3)
0.5 (2.1) 1.8 (1.6)
-0.5(2.5) 2.7 (1.9)
-5.3 (5.6) 1.5(1.1)
Table 10. Composite score [mean (SE)] Performance on Line for SRSs and controls: permutation analyses
of difference scores between exposure conditions.
SRS Control p
Gas/15% MTBE -clean air -12.0(12.7) -1.2(1.5) 0.30
Gas/15% MTBE-gasoline 5.8(4.2) 0.3(1.7) 0.17
Gas/15% MTBE -gas/i 1% MTBE 4.9(5.1) 1.2(2.3) 0.49
Gasoline -clean air -6.3 (12.1) -0.9(2.1) 0.69
Gas/i 1% MTBE -clean air -7.2(11.9) 0.0 (2.3) 0.56
Gas/i 1% MTBE -gasoline 0.9(2.2) -1.0(2.7) 0.63
Table 11. Subjects' awareness of exposure: percentage ofsubjects' guesses by exposure condition.
Subject's guess
Clean air Gasoline MTBE 11% MTBE 15%
Exposure condition (%) 1%) (%) (%)
SRS (n= 12)
Clean air 75(9) 8(1) 8(1) 8(1)
Gasoline 0(0) 25(3) 67(8) 8(1)
Gas/i 1% MTBE 0(0) 33(4) 42(5) 25(3)
Gas/15% MTBE 0(0) 8(1) 67 (8) 25(3)
Total guesses 19(9/48) 19(9/48) 46(22/48) 17(8/48)
Controls (n= 19)
Clean air 47(9) 16(3) 32(6) 5(1)
Gasoline 5(1) 16(3) 63(12) 16(3)
Gas/11% MTBE 16(3) 16(3) 53(10) 16(3)
Gas/15% MTBE 5(1) 21(4) 53(10) 21(4)
Total guesses 18(14/76) 17 (13/76) 50(38/76) 14(11/76)
The value in parentheses = n.
majority ofboth groups thought MTBE was
present when they were exposed to gasoline
only. Furthermore, if knowledge of MTBE
exposure was the determinant of symptoms,
then one would not expect the increased
symptom reports observed from 11% MTBE
to 15% MTBE. In the present study, symp-
tom responses could not be explained entire-
ly byawareness ofMTBEexposure.
A negative emotional association with
the odor of MTBE, particularly among the
SRSs, could produce increased heart rate and
muscle tension or decreased end-tidal CO2.
Such physiologic responses are associated
with symptoms such as headache and dizzi-
ness, the same symptoms as those attributed
to MTBE exposure. However, neither SRSs
nor controls exhibited significant changes on
any psychophysiologic measure in response
to odor cues perceived in the initial phase of
exposure to gasoline with 15% MTBE.
Thus, psychophysiologic indicators did not
support that the odor ofMTBE produced a
generalized sympathetic arousal as would
accompany a panic state at least for this rela-
tivelysmall subgroup ofSRSs.
The periodic ratings of odor intensity,
irritation, and pleasantness during each expo-
sure also did not suggest that the response of
either the SRSs or controls to the odors
changed differentially (i.e., exposure x time x
group interaction). Although the magnitude
ofthe SRS response to the odors ofall expo-
sure conditions, including clean air, was
greater than the controls, the response pattern
over time was not different between the
groups. Both groups rated the odor ofexpo-
sure to the gasolinewith orwithout MTBE as
increasingly more intense and less pleasant
over timewith the greatest increases occurring
between time 1 (5 min), before exposure and
the onset of exposure to gasoline with or
without MTBE. This change in ratings over
time, however, did not occur for the dean air
condition. Although not significant, the pat-
tern of rating for pleasantness suggested that
relative to the controls, the SRSs rated the
odor as increasingly unpleasant over the time
they were exposed to all gasoline mixtures.
Table 12. Odor ratings: mixed model analysis ofvariance forthe effects ofgroup, exposure condition, and time.
Intensity Irritation Pleasantness
Type ll SS df F p Type ll SS df F p Type ll SS df F p
Main effects
Groupa 13511.9 1,29 4.73 0.04d 13265.2 1,29 5.77 0.03d 66.0 1,26 4.07 0.05
Exposureb 14689.8 3,87 15.02 0.0001e 6285.5 3,87 10.05 .0001e 21.0 3,78 2.05 0.12
Timec 22246.6 3,87 34.89 0.0001 f 6701.7 3,87 14.27 0.0001 f 116.7 3,78 24.2 0.0001f
Interaction effects
Exposure x group 608.4 3,87 0.62 0.55 1633.3 3,87 2.61 0.07 2.9 3,78 0.3 0.82
Time xgroup 1239.3 3,87 1.94 0.16 409.1 3,87 0.87 0.41 13.7 3,78 2.8 0.07
Exposure xtime 6474.3 9,261 8.61 0.0001 1694.4 9,261 2.42 0.09 32.6 9,234 5.4 0.0001
Exposure xtime xgroup 762.2 9,261 1.01 0.41 821.6 9,261 1.18 0.32 12.0 9,234 2.0 0.06
SS, sum of squares.
aSRSsversus controls. bClean air, gasoline,gas/11% MTBE, orgas/15% MTBE. cMin 5, 10, 15, or 20. dSRS > controls. 0Gasoline,gas/11% MTBE, gas/15% MTBE> clean air. fMin 10, 15,20
>5.
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The changing pattern ofratings over time and
between exposure conditions was not signifi-
cant for ratings of irritation. Odor ratings
during exposure, however, do not support a
significant, differential odor response to gaso-
line, gasoline with 11% MTBE, or gasoline
with 15% MTBE for either group. Thus,
symptom results do not appear to be mediat-
ed by a negative or specific hedonic response
to MTBE at 15% in gasoline.
The current results reveal that the SRSs
chosen were indeed "sensitive" as illustrated
by greater baseline symptom scores and odor
ratings of irritation and intensity than con-
trols during every experimental condition. It
is noteworthy that, in contrast to the present
findings, no previous controlled exposure
study has documented significantly increased
symptoms in response to MTBE exposure
(7-9). However, this is the first study to test
directly the responses ofindividuals not only
self-reported as sensitive to MTBE but also
apparently more generally sensitive as indi-
cated by increased symptoms regardless of
exposure. Other investigators have recom-
mended this approach, as in the case ofsick
building syndrome, yet it is seldom under-
taken (29). Previous studies, in which sick
building syndrome (SBS) subjects were
exposed to mixtures ofvolatile organic com-
pounds known to pollute indoor air, also
found significantly increased symptom
reports among the SBS subjects relative to
controls (30,31). Thus, direct testing ofsub-
groups reporting unexpected symptoms in
response to low-level exposures may be nec-
essary to understand reported health effects.
The present study, however, also highlights
problems with the feasibility ofstudies with
sensitive subgroups given the constraints
required for controlled exposures, the rela-
tively small number of affected individuals
in the population, and the understandable
reticence of affected individuals to undergo
exposure to the chemical ofconcern.
The second factor that differentiated this
study from previous controlled exposure stud-
ies with MTBE was that exposure conditions
were designed to approximate what is experi-
enced in daily life. Therefore, subjects were
exposed to MTBE in gasoline at concentra-
tions comparable to those encountered at a
gasoline station (16). All previous studies
involved exposure to pure MTBE. As suggest-
ed by Nihlen et al. (;), it may be that when
MTBE is mixed with gasoline, a different
effect occurs from that seen with pure MTBE.
The intent of the present research
approach was to test directly both the expo-
sure conditions and the individuals pre-
sumed to be at highest risk (i.e., SRSs).
While ecologically valid, this approach
placed significant restrictions on subject
recruitment and therefore, on generalizability
of results. The number ofSRS subjects who
were healthy and also willing to participate in
an exposure study was small relative to the
numbers cited by community groups as
adversely affected by MTBE. Therefore, the
present results cannot be generalized to the
entire population of SRS individuals nor to
those who are SRSs with other health condi-
tions. Those most sensitive to MTBE may
have been least likely to volunteer for an
exposure study. This self-selection bias could
partially explain the present findings.
Furthermore, the relatively small sample size
may have reduced the power ofthe study. For
example, the SRSs reported more symptoms
at 15% MTBE versus clean air and 11%
MTBE, but the contrast with gasoline failed
to reach statistical significance. This variabili-
ty in results may be due to the small sample
size, but increasing sample size may or may
not increase the ability to detect significant
effects for anyofthe variables measured.
Although a dose-response effect was not
observed, the results suggested that increased
symptoms were associated with a threshold.
This possibility is plausible because com-
plaints in New Jersey occurred primarily
during oxygenated fuel season when MTBE
was present at 15%, but not during the
reformulated gas season when 11% MTBE
was present in gasoline. Unfortunately,
quantitative values for each participant's
exposure to MTBE before the study were
not available. Although baseline TBA levels
and questionnaires on vehicle use suggest
that some SRSs may have had more expo-
sure to MTBE prior to their participation in
the study, the effect on the threshold
observed cannot be assessed from the data.
Time constrained the use of additional
neurobehavioral tests or other objective
markers (e.g., tear film) that may have been
more sensitive to the effects ofexposure. For
example, the SRSs reported more symptoms
when exposed to MTBE at 15% in gasoline,
yet neurobehavioral performance, as mea-
sured, was not compromised as a result of
the exposure. Thus, any impact of these
symptoms on daily behavioral functions
connected to driving was not shown. With
different test batteries, previous controlled
exposure studies also reported no significant
neurobehavioral performance decrements
(8), lending validity to the negative neurobe-
havioral results found here.
Finally, it is also possible that use of
longer exposure durations or exposure con-
ditions that reflect ongoing exposure while
driving may have shown greater effects on
performance. For example, anecdotal reports
indicate that SRS subjects reported symptom
exacerbation while driving in traffic where
exhaust emissions are prevalent. The latter
could not have been completed in a CEF
study because of the high levels of carbon
monoxide in the exhaust and the complex
composition of exhaust in the atmosphere,
(e.g., fresh versus aged exhaust that includes
particles and gases).
Conclusions
Compared to controls, individuals who
reported they were sensitive to MTBE
reported more symptoms at baseline inde-
pendent ofexposure condition, suggesting a
generic, nonspecific sensitivity. Moreover,
these SRSs reported more symptoms than
controls in response to gasoline with 15%
MTBE than to clean air or to gasoline with
1 1% MTBE. This differential response to
gasoline with 15% MTBE was not explained
by specific knowledge of exposure or reac-
tions to the odor of exposure. Despite
increased symptoms in response to gasoline
with 15% MTBE, SRSs did not show any
concomitant decrements in simulated dri-
ving performance tests, and did not manifest
any significant psychophysiologic responses
with exposure. Furthermore, the present
study did not support a dose response to
MTBE exposure nor the specific symptoms
associated with MTBE that were suggested
in previous epidemiologic studies.
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